Short NJ, Daver N, Dinardo CD, Kadia T, et al. Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML. J Clin Oncol 2024;42:1499-1508.
PMID: 38277619